Engineering Tunable Helper Lipid Architecture to Improve Messenger RNA Lipid Nanoparticle Performance

Helper lipids are essential structural components of lipid nanoparticles (LNPs), yet systematic design principles linking helper lipid architecture to messenger RNA (mRNA) delivery performance remain poorly defined. Here we identify helper lipid architecture as a major, largely unexplored design lever for optimizing LNP performance. Using a modular library of more than 80 rationally designed helper lipids, we show that systematic variation in headgroup chemistry, linker topology, and tail cardinality reshapes both LNP biophysical behavior and biological performance. Martini molecular dynamics (MD) simulations combined with multimodal structural analyses reveal that high-performing scaffolds undergo a pH-dependent transition into fusogenic inverse hexagonal-like ordering, substantially lowering the energetic barrier for endosomal escape. These performance gains persist across the clinically relevant ALC-0315 and DLin-MC3-DMA platforms, establishing helper lipid architecture as a transferable design parameter across distinct ionizable lipid chemistries. Translating these design principles into function, optimized helper lipid formulations restore hepatic protein expression in a mouse model of ornithine transcarbamylase (OTC) deficiency and increase antigen expression and immunogenicity in both preclinical models and in the in vitro human MIMIC platform. Together, these findings establish helper lipids as tunable molecular actuators of potency, tolerability, and stability, offering an engineering framework for next-generation mRNA vaccines and therapeutics.

Authors

Institutions

Publication Details

Journal
Advanced Materials
Published
2026-11-17
DOI
https://doi.org/10.1002/adma.75746
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Engineering Tunable Helper Lipid Architecture to Improve Messenger RNA Lipid Nanoparticle Performance

Sudha V. Chivukula, Brian C. Schanen, Saswata Karmakar, Aurelie Deliot et al.
7 links
Advanced Materials
RNA Interference and Gene Delivery
article

Engineering Tunable Helper Lipid Architecture to Improve Messenger RNA Lipid Nanoparticle Performance

Sudha V. Chivukula, Brian C. Schanen, Saswata Karmakar, Aurelie Deliot, Jose Salvatico, Allison L. Dauner, Yuning J. Tang, Anusha Dias, Neha Kaushal, Saket Dolare, Chetan Poojari, Solene Bechelli, David Forgacs, Heesik Yoon, Mengwei Sun, Krishna Chaitanya Suddala, Rose Jolicoeur, Younan Ma, Shrirang Karve, Amita M. Vaidya, Ana Kume, Frank DeRosa, Ashish Sarode, Lingyun Liu, Dipen Parande, Régis Gervier, Zhongyu Li, Ranjitha Uppala, Hongfeng Deng, Ramesh Dasari, Chung Li Wu, Alex Shumate, Danielle McCulley, Hanming Zhang, Trent P. Northen, Zhen Hu, Michael Rieger, Jae‐Heon Kim
article en

Abstract

Helper lipids are essential structural components of lipid nanoparticles (LNPs), yet systematic design principles linking helper lipid architecture to messenger RNA (mRNA) delivery performance remain poorly defined. Here we identify helper lipid architecture as a major, largely unexplored design lever for optimizing LNP performance. Using a modular library of more than 80 rationally designed helper lipids, we show that systematic variation in headgroup chemistry, linker topology, and tail cardinality reshapes both LNP biophysical behavior and biological performance. Martini molecular dynamics (MD) simulations combined with multimodal structural analyses reveal that high-performing scaffolds undergo a pH-dependent transition into fusogenic inverse hexagonal-like ordering, substantially lowering the energetic barrier for endosomal escape. These performance gains persist across the clinically relevant ALC-0315 and DLin-MC3-DMA platforms, establishing helper lipid architecture as a transferable design parameter across distinct ionizable lipid chemistries. Translating these design principles into function, optimized helper lipid formulations restore hepatic protein expression in a mouse model of ornithine transcarbamylase (OTC) deficiency and increase antigen expression and immunogenicity in both preclinical models and in the in vitro human MIMIC platform. Together, these findings establish helper lipids as tunable molecular actuators of potency, tolerability, and stability, offering an engineering framework for next-generation mRNA vaccines and therapeutics.

Advanced Materials
Sanofi (France) (FR), Sanofi (United States) (US)
Sanofi
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon